Mitochondrial involvement in Alzheimer's disease

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1410, Issue 2, 1999, Pages 171-182

  Bonilla, Eduardo ^a,b   Tanji, Kurenai ^a   Hirano, Michio ^a   Vu, Tuan H ^a   DiMauro, Salvatore ^a   Schon, Eric A ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Aging; Alzheimer; Deletion; Hippocampus; Mitochondrial encephalomyopathy; Mitochondrion; mtDNA; Neuritic plaque; Neurofibrillary tangle; Neuropathology; Oxidative phosphorylation; Oxidative stress; Point mutation; Reactive oxygen species; Respiratory chain

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; GENE EXPRESSION; GENE MUTATION; HUMAN; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW;

ALZHEIMER DISEASE; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; HUMANS; IMMUNOHISTOCHEMISTRY; MITOCHONDRIA; MUTATION; NEURONS; OXIDATIVE STRESS;

EID: 0033028516     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2728(98)00165-0     Document Type: Review

References (96)

1. S. Anderson, A.T. Bankier, B.G. Barrell, M.H.L. de Bruijn, A.R. Coulson, J. Drouin, I.C. Eperon, D.P. Nierlich, B.A. Roe, F. Sanger, P.H. Schreier, A.J.H. Smith, R. Staden, I.G. Young, Sequence and organization of the human mitochondrial genome, Nature 290 (1981) 457-465.
2. R. Katzman, Alzheimer's disease, New Engl. J. Med. 314 (1986) 964-973.
3. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giufra, L. Haynes, N. Irving, L. James, R. Mant, P. Newton, K. Rooke, P. Roques, C. Talbot, M. Pericak-Vance, A. Roses, R. Williamson, M. Rossor, M. Owen, J. Hardy, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991) 704-709.
4. R. Sherrington, E.E. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, K. Holman, T. Tsuda, L. Mar, J.F. Foncin, A.C. Bruni, M.P. Montesi, S. Sorbi, Y. Rainero, L. Pinessi, L. Nee, Y. Chumakov, D. Pollen, A. Brookes, P. Sanseau, J. Polisnky, W. Wasco, H.A.R. Da Silva, J.L. Haines, M.A. Pericak-Vance, R.E. Tanzi, A.D. Roses, P.E. Fraser, J.M. Rommens, P.H. George-Hyslop, Cloning a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature 375 (1995) 754-760.
5. E. Levy-Lahad, W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, W.H. Pettingell, C.-E. Yu, P.D. Jondro, S.D. Schmidt, K. Wand, A.C. Crowley, Y.H. Fu, S.Y. Fuenette, D. Galas, E. Nemens, E.M. Wijsman, T.D. Bird, G.D. Schellenberg, R.E. Tanzi, Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science 269 (1995) 973-977.
6. D.C. Wallace, Mitochondrial genetics: a paradigm for aging and degenerative diseases?, Science 256 (1992) 628-632.
7. M.F. Beal, Aging, energy, and oxidative stress in neurodegenerative diseases, Ann. Neurol. 38 (1995) 357-366.
8. A.H.V. Schapira, Oxidative stress and mitochondrial dysfunction in neurodegeneration, Curr. Opin. Neurol. 9 (1996) 260-264.
9. R.D. Terry, R. Katzman, Senile dementia of the Alzheimer type, Ann. Neurol. 14 (1983) 497-506.
10. B.T. Hyman, A.R. Damasio, G.W. Van Hoesen, C.L. Barnes, Alzheimer's disease: cell specific pathology isolates the hippocampal formation, Science 298 (1984) 83-95.
11. P.R. Hof, K. Cox, W.G. Young, M.R. Celio, J. Rogers, J.H. Morrison, Paralbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer disease, J. Neuropathol. Exp. Neurol. 50 (1991) 451-462.
12. P.R. Hof, J.H. Morrison, Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease, Exp. Neurol. 111 (1991) 293-301.
13. E. Masliah, R.D. Terry, M. Alford, R. De Teresa, L.A. Hansen, Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease, Am. J. Pathol. 138 (1991) 235-246.
14. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. De Teresa, R. Hill, L.A. Hansen, R. Katzman, Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol. 30 (1991) 572-580.
15. B.T. Hyman, G.W. Van Hoesen, L.J. Kromer, A.R. Damasio, Perforant pathway changes and the memory impairment of Alzheimer's disease, Ann. Neurol. 20 (1986) 472-481.
16. D.G. Amaral, M.P. Witter, The three-dimensional organization of the hippocampal formation: a review of anatomical data, Neuroscience 31 (1989) 571-591.
17. B.T. Hyman, G.W. Van Hoesen, A.R. Damasio, Memory-related neural systems in Alzheimer's disease: an anatomic study, Neurology 40 (1990) 1721-1730.
18. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle, M.R. DeLong, Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science 215 (1982) 1237-1239.
19. E.A. Schon, E. Bonilla, S. DiMauro, Mitochondrial DNA mutations and pathogenesis, J. Bioenerg. Biomembr. 29 (1997) 131-149.
20. S. DiMauro, E. Bonilla, Mitochondrial encephalomyopathies, in: R.N. Rosenberg, S.B. Prusiner, S. DiMauro, R.L. Barchi (Eds.), The Molecular and Genetic Basis of Neurological Disease, Butterworth-Heinemann, Boston, pp. 189-200.
21. E.A. Schon, R. Rizzuto, C.T. Moraes, H. Nakase, M. Zeviani, S. DiMauro, A direct repeat is a hotspot for large-scale deletions of human mitochondrial DNA, Science 244 (1989) 346-349.
22. S. Mita, R. Rizzuto, C.T. Moraes, S. Shanske, E. Arnaudo, G. Fabrizi, Y. Koga, S. DiMauro, E.A. Schon, Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA, Nucleic Acids Res. 18 (1990) 561-567.
23. H. Nakase, C.T. Moraes, R. Rizzuto, A. Lombes, S. DiMauro, E. A. Schon, Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis, Am. J. Hum. Genet. 46 (1990) 418-427.
24. S.-i. Ikebe, M. Tanaka, K. Ohno, W. Sato, K. Hattori, T. Kondo, Y. Mizuno, T. Ozawa, Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence, Biochem. Biophys. Res. Commun. 170 (1990) 1044-1048.
25. G.A. Cortopassi, N. Arnheim, Detection of a specific mitochondrial DNA deletion in tissues of older humans, Nucleic Acids Res. 18 (1990) 6927-6933.
26. S. Simonetti, X. Chen, S. DiMauro, E.A. Schon, Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR, Biochim. Biophys. Acta 1180 (1992) 113-122.
27. C. Zhang, A. Baumer, R.J. Maxwell, A.W. Linnane, P. Nagley, Multiple mitochondrial DNA deletions in an elderly human individual, FEBS Lett. 297 (1992) 34-38.
28. X. Chen, S. Simonetti, S. DiMauro, E.A. Schon, Accumulation of mitochondrial DNA deletions in organisms with various lifespans, Bull. Mol. Biol. Med. 18 (1993) 57-66.
29. F. Pallotti, X. Chen, E. Bonilla, E.A. Schon, Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging, Am. J. Hum. Genet. 59 (1996) 591-602.
30. M. Corral-Debrinski, T. Horton, M.T. Lott, J.M. Shoffner, M.F. Beal, D.C. Wallace, Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age, Nature Genet. 2 (1992) 324-329.
31. N.W. Soong, D.R. Hinton, G. Cortopassi, N. Arnheim, Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain, Nature Genet. 2 (1992) 318-323.
32. D. Harman, Free radical theory of aging: origin of life, evolution and aging, Age 3 (1980) 100-102.
33. D. Harman, Free radical theory of aging: a hypothesis on pathogenesis of senile dementia of the Alzheimer's type, Age 16 (1993) 23-30.
34. I. Volicer, P.B. Crino, Involvement of free radicals in dementia of the Alzheimer type: a hypothesis, Neurobiol. Aging 11 (1990) 567-571.
35. G. Benzi, A. Moretti, Are oxygen free radicals involved in Alzheimer's disease?, Neurobiol. Aging 16 (1995) 661-674.
36. J.T. Coyle, P. Puttfarcken, Oxidative stress, glutamate and neurodegenerative disorders, Science 262 (1993) 689-695.
37. C.D. Smith, J.M. Carney, P.E. Starke-Reed, C.N. Oliver, E.R. Stadtman, R.A. Floyd, W.R. Markesbery, Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease, Proc. Natl. Acad. Sci. USA 88 (1991) 10540-10543.
38. K. Hensley, N. Hall, R. Subramanian, P. Cole, M. Harris, M. Aksenov, M. Aksenova, S.P. Gabitta, J.F. Wu, J.M. Carney, M. Lovell, W.R. Markesbery, D.A. Butterfield, Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation, J. Neurochem. 65 (1995) 2146-2156.
39. M.A. Lovell, W.D. Ehman, S.M. Butler, W.R. Markesbery, Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease, Neurology 45 (1995) 1594-1601.
40. M.D. Ledesma, P. Boney, C. Colaco, J. Avila, Analyses of microtubule-associated protein tau glycation in paired helical filaments, J. Biol. Chem. 269 (1994) 21614-21619.
41. S.D. Yan, X. Chen, A.M. Schmidt, J. Brett, G. Godman, Y.S. Zou, C.W. Scott, C. Caputo, T. Frappier, M.A. Smith, G. Perry, S.H. Yen, D. Stern, Glycated tau protein in Alzheimer's disease: a mechanism for induction of oxidant stress, Proc. Natl. Acad. Sci. USA 91 (1994) 7787-7791.
42. M.P. Vitek, K. Bhattacharya, J.M. Glendening, E. Stopa, H. Vlassara, R. Bucala, K. Manogue, A. Cerami, Advanced glycation end products contribute to amyloidosis in Alzheimer's disease, Proc. Natl. Acad. Sci. USA 91 (1994) 4766-4770.
43. P.F. Good, P. Werner, A. Hsu, C.W. Olanow, D.P. Perl, Evidence for neuronal oxidative damage in Alzheimer's disease, Am. J. Pathol. 149 (1996) 21-28.
44. M.A. Smith, G. Perry, P.L. Richey, L.M. Sayre, V.E. Anderson, M.F. Beal, N. Kowall, Oxidative damage in Alzheimer's (letter), Nature 382 (1996) 120-121.
45. W. Gsell, R. Conrad, M. Hickethier, E. Sofic, L. Frolich, I. Wichart, K. Jellinger, G. Moll, G. Ransmayr, H. Beckmann, P. Riederer, Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type, J. Neurochem. 64 (1995) 1216-1223.
46. K. Hensley, M.J. Carney, M.P. Mattson, M. Aksenova, M. Karris, R. A. Floyd, D.A. Butterfield, A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease, Proc. Natl. Acad. Sci. USA 91 (1994) 3270-3274.
47. M.E. Harris, K. Hensley, D.A. Butterfield, R.A. Leedle, J.M. Carney, Direct evidence of oxidative injury produced by the Alzheimer β-amyloid peptide (1-40) in cultured hippocampal neurons, Exp. Neurol. 131 (1995) 193-202.
48. R.C. Griggs, V. Askanas, S. DiMauro, A.G. Engel, G. Karpati, J.R. Mendell, L.P. Rowland, Inclusion body myositis and myopathies, Ann. Neurol. 38 (1995) 705-713.
49. V. Askanas, J. McFerrin, S. Baque, R.B. Alvarez, E. Sarkozi, W.K. Engel, Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle, Proc. Natl. Acad. Sci. USA 93 (1996) 1314-1319.
50. P. Mecocci, U. MacGarvey, A.E. Kaufman, D. Koontz, J.M. Shoffner, D.C. Wallace, M.F. Beal, Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain, Ann. Neurol. 34 (1993) 609-616.
51. P. Mecocci, U. MacGarvey, M.F. Beal, Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease, Ann. Neurol. 36 (1994) 747-751.
52. M. Corral-Debrinski, T. Horton, M.T. Lott, J.M. Shoffner, A.C. McKee, M.F. Beal, B.H. Graham, D.C. Wallace, Marked changes in mitochondrial DNA deletion levels in Alzheimer brains, Genomics 23 (1994) 471-476.
53. R. Duara, R.F. Lopez-Alberola, W.W. Barker, D.A. Loewenstein, M. Zatinsky, C.E. Eisdorfer, G.B. Weinberg, A comparison of familial and sporadic Alzheimer's disease, Neurology 43 (1993) 1377-1384.
54. R. Mielke, K. Herholz, M. Grond, J. Kessler, W.D. Heiss, Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas, Dementia 5 (1994) 36-41.
55. R.P. Friedland, T.F. Budinger, E. Koss, B.A. Ober, Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization, Neurosci. Lett. 33 (1985) 235-240.
56. J.V. Haxby, C.L. Grady, R. Duara, N. Schlageter, G. Berg, S.I. Rapoport, Neocortical metabolic abnormalities precede nonmemory cognitive deficits in early Alzheimer's-type dementia, Arch. Neurol. 43 (1986) 882-885.
57. W.D. Parker, J.K. Parks, C.M. Filley, B.K. Kleinschmidt-Demasters, Electron transport chain defects in Alzheimer's disease brain, Neurology 44 (1994) 1090-1096.
58. W.D. Parker, J.K. Parks, Cytochrome c oxidase in Alzheimer's disease brain, Neurology 45 (1995) 482-486.
59. S.J. Kish, C. Bergeran, A. Rajput, S. Dozie, F. Mastrogiacomo, L.J. Chang, J.M. Wilson, L.M. DiStefano, J.N. Nobrega, Brain cytochrome oxidase in Alzheimer's disease, J. Neurochem. 59 (1992) 776-779.
60. E.M. Mutisya, A.C. Bowling, M.F. Beal, Cortical cytochrome oxidase activity is reduced in Alzheimer's disease, J. Neurochem. 63 (1994) 2179-2184.
61. P. Chagnon, C. Betard, Y. Robitaille, A. Cholette, D. Gauvreau, Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases, Mol. Neurosci. 6 (1995) 711-715.
62. N.A. Simonian, B.T. Hyman, Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation, J. Neuropathol. Exp. Neurol. 52 (1993) 580-585.
63. N.A. Simonian, B.T. Hyman, Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation, J. Neuropathol. Exp. Neurol. 53 (1994) 508-512.
64. C.D. Bedetti, Immunocytological demonstration of cytochrome c oxidase with an immunoperoxidase method, J. Histochem. Cytochem. 33 (1985) 446-452.
65. R.F. Hevner, M.T.T. Wong-Riley, Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionally regulated by functional activity in neurons, J. Neurosci. 13 (1993) 1805-1819.
66. R.C. Scarpulla, Nuclear respiratory factors and the pathways of nuclear-mitochondrial interactions, Trends Cardiovasc. Med. 6 (1996) 39-45.
67. 0 ATP-synthase defects in Alzheimer's disease revealed by blue native polyacrylamide gel electrophoresis, Eur. J. Biochem. 227 (1995) 916-921.
68. K.F.R. Sheu, Y.T. Kim, J.P. Blass, M.E. Weksler, An immunohistochemical study of pyruvate dehydrogenase deficit in Alzheimer's disease brain, Ann. Neurol. 17 (1985) 444-449.
69. F. Mastrogiacomo, C. Bergeron, S.J. Kish, Brain α-ketoglutarate dehydrogenase activity in Alzheimer's disease, J. Neurochem. 6 (1993) 2007-2014.
70. K. Chandrasekaran, K. Hatanpää, D.R. Brady, S.I. Rapoport, Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease, Exp. Neurol. 142 (1996) 80-88.
71. S.I. Rapoport, K. Hatanpää, D.R. Brady, K. Chandrasekaran, Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer's disease, Neurodegeneration 5 (1996) 473-476.
72. K. Hatanpää, D.R. Brady, J. Stoll, S.I. Rapoport, K. Chandrasekaran, Neuronal activity and early neurofibrillary tangles in Alzheimer's disease, Ann. Neurol. 40 (1996) 411-420.
73. K. Chandrasekaran, K. Hatanpää, S.I. Rapoport, D.R. Brady, Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer's disease, Mol. Brain Res. 44 (1997) 99-104.
74. B.J. Blanchard, T. Park, W.J. Fripp, L.S. Lerman, V.M. Ingram, A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue, Neuroreport 4 (1993) 799-802.
75. L. Cavelier, E.E. Jazin, I. Eriksson, J. Prince, U. Bave, L. Oreland, U. Gyllenstein, Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics, Genomics 29 (1995) 217-224.
76. S.D. Edland, J.M. Silverman, E.R. Peskind, D. Tsuang, E. Wijsman, J.C. Morris, Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance, Neurology 47 (1996) 254-256.
77. F.H. Lin, R. Lin, H.M. Wisniewski, Y.W. Hwang, I. Grundke-Iqbal, G. Healy-Louie, K. Iqbal, Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains, Biochem. Biophys. Res. Commun. 182 (1992) 238-246.
78. V. Petruzzella, X. Chen, E.A. Schon, Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer's disease?, Biochim. Biophys. Res. Commun. 186 (1992) 491-497.
79. S. Kösel, R. Egensperger, P. Mehraein, M.B. Graeber, No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease, Biochem. Biophys. Res. Commun. 203 (1994) 745-759.
80. N.M. Schnopp, S. Kösel, R. Egensperger, M.B. Graeber, Regional heterogeneity of mtDNA heteroplasmy in parkinsonian brain, Clin. Neuropathol. 15 (1996) 348-352.
81. B. Janetzky, C. Schmid, F. Bischof, L. Frolich, W. Gsell, R.N. Kalaria, P. Riederer, H. Reichmann, Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases, Eur. Neurol. 36 (1996) 149-153.
82. J.M. Shoffner, M.D. Brown, A. Torroni, M.T. Lott, M.F. Cabell, S.S. Mirra, M.F. Beal, C.-C. Yang, M. Gearing, R. Salvo, R.L. Watts, J.L. Juncos, L.A. Hansen, B.J. Crain, M. Fayad, C.L. Reckord, D.C. Wallace, Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients, Genomics 17 (1993) 171-184.
83. A4336G mutation with Alzheimer's and Parkinson's diseases, Neuropathol. Appl. Neurobiol. 23 (1997) 315-321.
84. T. Hutchin, G. Cortopassi, A mitochondrial DNA clone is associated with increased risk for Alzheimer disease, Proc. Natl. Acad. Sci. USA 92 (1995) 6892-6895.
85. M.A. Wragg, C.J. Talbot, J.C. Morris, C.L. Lendon, A.M. Goate, No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant, Neurosci. Lett. 201 (1995) 107-110.
86. U. Mayr-Wohlfart, G. Rodel, A. Henneberg, Mitochondrial tRNA(Gln) and tRNA(Thr) gene variants in Parkinson's disease, Eur. J. Med. Res. 2 (1997) 111-113.
87. M.D. Brown, J.M. Shoffner, Y.L. Kim, A.S. Jun, B.H. Graham, M.F. Cabell, D.S. Gurley, D.C. Wallace, Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients, Am. J. Med. Genet. 61 (1996) 283-289.
88. R.E. Davis, S. Miller, C. Herrnstadt, S.S. Ghosh, E. Fahy, L.A. Shinobu, D. Galasko, L.J. Thai, M.F. Beal, N. Howell, W.D. Parker, Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA 94 (1997) 4526-4531.
89. M. Hirano, A. Shtilbans, R. Mayeux, M.M. Davidson, S. DiMauro, J.A. Knowles, E.A. Schon, Apparent mtDNA heteroplasmy in Alzheimer disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes, Proc. Natl. Acad. Sci. USA 94 (1997) 14894-14899.
90. D.C. Wallace, C. Stugard, D. Murdock, T. Schurr, M.D. Brown, Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations, Proc. Natl. Acad. Sci. USA 94 (1997) 14900-14905.
91. M.P. King, G. Attardi, Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation, Science 246 (1989) 500-503.
92. Leu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes, Mol. Cell Biol. 12 (1992) 480-490.
93. S.W. Miller, P.A. Trimmer, W.D. Parker, R.E. Davis, Creation and characterization of mitochondrial DNA-depleted cell lines with 'neuronal-like' properties, J. Neurochem. 67 (1996) 1897-1907.
94. R.H. Swerdlow, J.K. Parks, D.S. Cassarino, D.J. Maguire, R.S. Maguire, J.P.J. Bennett, R.E. Davis, W.D.J. Parker, Cybrids in Alzheimer's disease: a cellular model of the disease?, Neurology 49 (1997) 918-925.
95. J.P. Sheehan, R.H. Swerdlow, S.W. Miller, R.E. Davis, J.K. Parks, W.D. Parker, J.B. Tuttle, Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease, J. Neurosci. 17 (1997) 4612-4622.
96. E.A. Schon, E.A. Shoubridge, C.T. Moraes, Cybrids in Alzheimer's disease: a cellular model of the disease? (letter), Neurology 51 (1998) 326-327.